NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

US Tariff Measures Leave $34.27 Billion in Indian Exports Duty-Free

Total US imports from India stood at $87.7 billion in 2024, with approximately $34.27 billion remaining exempt under the revised tariff framework. Within this, $5.77 billion in civil aviation-related exemptions are accounted for.

The proposed tariff measures under Section 122 of the Trade Act of 1974 allow for duties of up to 15 percent for up to 150 days. These measures preserve exemptions for pharmaceuticals and electronics, while adding new carve-outs such as civil aviation products. The exemptions were under negotiation as part of the interim trade discussions between India and the US, scheduled for conclusion in March.

Key Exempted Product Categories

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The top 10 exempted product categories account for nearly $24 billion, or about 70 percent of all duty-free trade under the proposed structure.

  • Pharmaceuticals dominate the list, with medicaments in dosage form packaged for retail accounting for over $10.6 billion in exports.
  • Electronics and telecom equipment represent the next-largest segment, with smartphone exports amounting to nearly $6.8 billion.
  • Petroleum products and engineering goods also form a sizeable portion of the exempted trade, with refined petroleum exports contributing significantly.

Investor Takeaway

Investors should monitor the outcome of the interim trade discussions between India and the US to gauge the potential impact on trade and tariffs.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.